Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 3, 1997, Pages 315-318

  Morris Jones, Stephen D ^a   Easterbrook, Philippa J ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; PENTAMIDINE; PRIMAQUINE;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PNEUMOCYSTIS PNEUMONIA; SHORT SURVEY; SIDE EFFECT;

ADRENAL CORTEX HORMONES; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; CLINDAMYCIN; DRUG THERAPY, COMBINATION; HUMANS; PENTAMIDINE; PNEUMONIA, PNEUMOCYSTIS; PRIMAQUINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0030754712     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.3.315     Document Type: Short Survey

References (39)

1. Hoover, D. R., Saah, A. J., Bacellar, H., Phair, J., Detels, R., Anderson, R. et al. (1993). Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. New England Journal of Medicine 329, 1922-6.
2. Pitkin, A. D., Grant, A. D., Foley, N. M. & Miller, R. F. (1993). Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1. Thorax 48, 204-7.
3. Katz, M. H., Hessol, N. A., Buchbinder, S. P., Hirozawa, A., O'Malley, P. & Holmberg, S. D. (1994). Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. Journal of Infectious Diseases 170, 198-202.
4. Duchin, J. S., Sohlberg, B., Buskin, S., Hopkins, S., Simon, P. (1996). Risk factors for Pneumocystis carinii pneumonia: delayed diagnosis of HIV-infection and failure to receive prophylactic therapy. In Proceedings of the Eleventh International Conference on AIDS, Vancouver, Canada, 1996. Abstract TuB114.
5. Flepp, M., Ledergerber, B., Schenker, C., Egger, M., Gebhardt, M. & Luthy, R. (1996). Pneumocystis carinii pneumonia as first AIDS indicator disease in the era of primary prophylaxis - why does it still occur? In Proceedings of the Eleventh International Conference on AIDS, Vancouver, Canada, 1996. Abstract TuB113.
6. Miller, R. F., Le Noury, J., Corbett, E. L., Felton, J. M. & De Cock, K. M. (1996). Pneumocystis carinii infection: current treatment and prevention. Journal of Antimicrobial Chemotherapy 37, Suppl. B, 33-53.
7. Sattler, F. R., Cowan, R., Nielsen, D. M. & Ruskin, J. (1988). Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Annals of Internal Medicine 109, 280-7.
8. Safrin, S., Finkelstein, D. M., Feinberg, J., Frame, P., Simpson, G., Wu, A. et al. (1996). Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. Annals of Internal Medicine 124, 792-802.
9. Black, J. R., Feinberg, J., Murphy, R. L., Fass, R. J., Carey, J. & Sattler, F. R. (1991). Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS. European Journal of Clinical Microbiology and Infectious Diseases 10, 204-7.
10. Black, J. R., Feinberg, J., Murphy, R. L., Fass, R. J., Finkelstein, D., Akil, B. et al. (1994). Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS clinical trials group 044. Clinical Infectious Diseases 18, 905-13.
11. Hughes, W. T., Gray, V. L., Gutteridge, W. E., Latter, V. S. & Pudney, M. (1990). Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. Antimicrobial Agents and Chemotherapy 34, 225-8.
12. Hughes, W., Leoung, G., Kramer, F., Bozzette, S. A., Safrin, S., Frame, P. et al. (1993). Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. New England Journal of Medicine 328, 1521-7.
13. Dohn, M. N., Weinberg, W. G., Torres, R. A., Follansbee, S. E., Caldwell, P. T., Scott, J. D. et al. (1994). Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Annals of Internal Medicine 121, 174-80.
14. Bozzette, S. A., Sattler, F. R., Chiu, J., Wu, A. W., Gluckstein, D., Kemper, C. et al. (1990). A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. New England Journal of Medicine 323, 1451-7.
15. Gagnon, S., Boota, A. M., Fischl, M. A., Baier, H., Kirksey, O. W. & La Voie, L. (1990). Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. New England Journal of Medicine 323, 1444-50.
16. Bozzette, S. A. & Morton, S. C. (1995). Reconsidering the use of adjunctive corticosteroids in Pneumocystis pneumonia? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 8, 345-7.
17. Caumes, E., Roudier, C., Rogeaux, O., Bricaire, F. & Gentilini, M. (1994). Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia. Clinical Infectious Diseases B18, 319-23.
18. Sleasman, J. W., Hemenway, C., Klein, A. S. & Barrett, D. J. (1993). Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia. American Journal of Diseases of Children 147, 30-4.
19. Nelson, M. R., Erskine, D., Hawkins, D. A. & Gazzard, B. G. (1993). Treatment with corticosteroids - a risk factor for the development of clinical cytomegalovirus disease in AIDS. AIDS 7, 375-8.
20. Jensen, A.-M. B., Lundgren, J. D., Benfield, T., Nielsen, T. L. & Vestbo, J. (1995). Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? Chest 108, 411-4.
21. Walzer, P. D. (1991). Pneumocystis carinii - new clinical spectrum? New England Journal of Medicine 324, 263-5.
22. Gallant, J. E., McAvinue, S. M., Moore, R. D., Bartlett, J. G., Stanton, D. L. & Chaisson, R. E. (1995). The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia. Chest 107, 1018-23.
23. Kaplan, J. E., Masur, H., Holmes, K. K., Wilfert, C. M., Sperling, R., Baker, S. A. et al. (1995). USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. Clinical Infectious Diseases 21, Suppl. 1, S12-31.
24. Locke, A., Meshnick, S., Lane, B., Cannon, M., Kileen, A., Beals, T. et al. (1997). Mutations in Pneumocystis carinii associated with prophylaxis breakthroughs in AIDS patients. In Proceedings of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997. Abstract No. 3.
25. Simonds, R. J., Oxotby, M. J., Caldwell, M. B., Gwinn, M. L. & Rogers, M. F. (1993). Pneumocystis carinii pneumonia among US children with perinatally acquired immunodeficiency virus infection. Journal of the American Medical Association 270, 470-3.
26. Wilfert, C. M., Masur, H., Gross, P. A., Kaplan, J. E., Holmes, K. K., Phair, J. P. et al. (1995). Quality standard for the prophylaxis of Pneumocystis carinii pneumonia in infants and children born to women infected with human immunodeficiency virus. Clinical Infectious Diseases 21 Suppl. 1, S132-3.
27. Bozzette, S. A., Finkelstein, D. M., Spector, S. A., Frame, P., Powderly, W. G., He, W. et al. (1995). A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 332, 693-9.
28. Ioannidis, J. P. A., Cappelleri, J. C., Skolnik, P. R., Lau, J. & Sacks, H. S. (1996). A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Archives of Internal Medicine 156, 177-88.
29. Saah, A. J., Hoover, D. R., Peng, Y., Phair, J. P., Visscher, B., Kingsley, L. A. et al. (1995). Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Journal of the American Medical Association 273, 1197-202.
30. Dunne, M. W., Havlir, D., Dube, M., Sattler, F., Forthal, D., Kemper, C. et al. (1996). Prevention of Pneumocystis carinii pneumonia with azithromycin. In Proceedings of the Eleventh International Conference on AIDS, Vancouver, 1996. Abstract TuB410.
31. Jung, A. C., Douglas, S. & Paauw, D. S. (1994). Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Archives of Internal Medicine 154, 2402-6.
32. Gluckstein, D. & Ruskin, J. (1995). Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ. Clinical Infectious Diseases 20, 849-53.
33. Bachmeyer, C., Salmon, D., Guerin, C., Barre, C., Hazebroucq, G., Sicard, D. et al. (1995). Trimethoprim-sulphamethoxazole desensitization in HIV-infected patients: an open study. AIDS 9, 299-300.
34. Piketty, C., Gilquin, J. & Kazatchkine, M. D. (1995). Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Journal of Infectious Diseases 172, 611.
35. Beardsall, A. D., Coker, K., Woodfall, B. & Conway, B. (1996). Cotrimoxazole (TMP-SMX) desensitization using adjunctive steroid therapy in HIV/AIDS patients. In Proceedings of the Eleventh International Conference on AIDS, Vancouver, 1966. Abstract TuB414.
36. Jorde, U. P., Horowitz, H. W. & Wormser, G. P. (1993). Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals. AIDS 7, 355-9.
37. Para, M. F., Dohn, M., Frame, P., Becker, S., Finkelstein, D. & Walawander, A. for the ACTG study team (1997). ACTG 268 trial-gradual initiation of trimethoprim/sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia. In Proceedings of the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997. Abstract No. 2.
38. Sperling, R. S. & Stratton, P. (1992). Treatment options for human immunodeficiency virus-infected pregnant women. Obstetrics and Gynecology 79, 433-8.
39. Briggs, G. G., Freeman, R. K. & Yaffe, S. J. (1990). Drugs in Pregnancy and Lactation. A Reference Guide to Fetal and Neonatal Risk, 3rd edn. Williams & Wilkins, Baltimore, MD.